Ferramentas Pessoais
Você está aqui: Entrada Notícias Vera Moura

Vera Moura




Vera Dantas Moura
CEO, TREAT U (Bluepharma)


Vera Dantas Moura completed her degree in Pharmaceutical Sciences and has a PhD in Pharmaceutical Technology from the Faculty of Pharmacy, University of Coimbra, Portugal. She collaborated with the Tech Transfer Office from the University of Coimbra and mentored several Entrepreneurship Programs. Member of research projects in the area of Oncology, she is PI in three projects funded by Regional European Funds. Co-author of scientific publications in peer-reviewed journals, oral communications/posters presented in international scientific meetings, Vera is also co-author of three patents granted in EU and US and in 2 PCTs pending. Vera was awarded with the Best PhD Thesis Award 2011 from the Portuguese Society of Pharmaceutical Sciences (SPCF) and the Spanish-Portuguese Local Chapter of Controlled Release Society (SPLC-CRS). Vera Moura is co-founder and the Chief Executive Officer of TREAT U. The company was distinguished by Maksen as a top 5 company for innovation and economic impact and is dedicated to the research and development of nanotechnology-based platforms for the specific (targeted) delivery of agents with pharmacological interest for human health.



"Novel nanomedicines for cancer treatment"

TREAT U is a drug development company focused on targeted strategies for subtypes of cancer that represent unmet medical needs. We develop functionalized drug delivery nanoparticles directed to the tumor microenvironment, offering new personalized treatment options to patients diagnosed with subtypes of cancer that have no specific treatments available.


[voltar ao programa | back to the programme]